Abstract:Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder. Affecting 5%-10% 1 Li R. Zhang Q. Yang D. Li S. Lu S. Wu X. et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013; 28: 2562-2569 Crossref PubMed Scopus (188) Google Scholar of reproductive-aged women, PCOS is characterized by hyperandrogenemia, anovulation, and insulin resistance (IR), with long-term effects throughout the different stages of a woman's life. During gestation, women with PCOS have greater androgen concentrations. 2 Sir-Petermann T. Maliqueo M. Angel B. Lara H.E. Perez-Bravo F. Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002; 17: 2573-2579 Crossref PubMed Google Scholar Intrauterine exposure to high androgen concentrations may cause fetal reprogramming or placental changes through epigenetic regulation or other mechanisms, thus causing changes in multiple systems in the offspring and ultimately affecting growth and development. The hormonal and metabolic alterations have been found in brothers of women with PCOS, 3 Sam S. Coviello A.D. Sung Y.A. Legro R.S. Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008; 31: 1237-1241 Crossref PubMed Scopus (45) Google Scholar ,4 Torchen L.C. Kumar A. Kalra B. Savjani G. Sisk R. Legro R.S. et al. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016; 106: 50-55 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar which may reflect the effects of PCOS susceptibility genes or programming effects of the intrauterine environment. Furthermore, a greater risk of pregnancy complications, 5 Palomba S. de Wilde M.A. Falbo A. Koster M.P. La Sala G.B. Fauser B.C. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015; 21: 575-592 Crossref PubMed Scopus (163) Google Scholar , 6 Damm P. Houshmand-Oeregaard A. Kelstrup L. Lauenborg J. Mathiesen E.R. Clausen T.D. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016; 59: 1396-1399 Crossref PubMed Scopus (182) Google Scholar , 7 Walker C.K. Krakowiak P. Baker A. Hansen R.L. Ozonoff S. Hertz-Picciotto I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr. 2015; 169: 154-162 Crossref PubMed Scopus (136) Google Scholar the use of metformin during pregnancy, 8 Rowan J.A. Rush E.C. Plank L.D. Lu J. Obolonkin V. Coat S. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018; 6: e000456 Crossref PubMed Google Scholar and maternal metabolic abnormalities (including obesity or IR 9 Drake A.J. Reynolds R.M. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction. 2010; 140: 387-398 Crossref PubMed Scopus (278) Google Scholar ,10 Fusco S. Spinelli M. Cocco S. Ripoli C. Mastrodonato A. Natale F. et al. Maternal insulin resistance multigenerationally impairs synaptic plasticity and memory via gametic mechanisms. Nat Commun. 2019; 10: 4799 Crossref PubMed Scopus (0) Google Scholar ) may be implicated in the effects on offspring.

Genome-Wide Association Study Identifies Susceptibility Loci for Polycystic Ovary Syndrome on Chromosome 2p16.3, 2p21 and 9Q33.3

Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

Genomic and proteomic evidence for hormonal and metabolic foundations of polycystic ovary syndrome

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature

Genetic Studies on Polycystic Ovary Syndrome

Identifying Novel Genetic Loci Associated with Polycystic Ovary Syndrome Based on Its Shared Genetic Architecture with Type 2 Diabetes.

Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins

Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview

Integrated Analyses for Genetic Markers of Polycystic Ovary Syndrome with 9 Case-Control Studies of Gene Expression Profiles

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome

Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci

Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women

Genome-wide association study for SNPs associated with PCOS in human patients

Molecular genetics of polycystic ovary syndrome: an update

Body mass index stratified meta-analysis of genome-wide association studies of polycystic ovary syndrome in women of European ancestry